CC
SPPI

Centiva Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Centiva Capital’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-28,898
Closed -$108K – 1708
2021
Q2 		$108K Buy
+28,898
New +$100K ﹤0.01% 1255

Other funds holding SPPI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Centiva Capital's SPPI Position: Q3 2021 in Review

Centiva Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2021, closing a stake of 28,898 shares — an estimated $108K sold.

Centiva Capital first reported a position in SPPI in Q2 2021 and held it in 1 quarter. The position peaked at $108K in Q2 2021. 147 funds tracked by Wall St. Rank hold SPPI as of Q3 2021.

  • Centiva Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2021 after selling out during the quarter.
  • Centiva Capital sold 28,898 Spectrum Pharmaceuticals Inc shares in Q3 2021, an estimated $108K.
  • Centiva Capital first reported a position in Spectrum Pharmaceuticals Inc in Q2 2021 and held it in 1 quarter.
  • Centiva Capital's Spectrum Pharmaceuticals Inc position peaked at $108K in Q2 2021.
  • 147 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2021.

Based on Centiva Capital's 13F filing for Q3 2021, filed 15 Nov 2021.